Navigation Links
SASMAR Announces FDA Approval for Its Personal Lubricants in the United States

Brussels, Belgium (PRWEB) October 01, 2013

SASMAR announced today that the U.S. Food and Drug Administration (FDA) has approved the full range of SASMAR® Brand of personal lubricant products for sale in the United States of America. SASMAR® Brand personal lubricants are formulated for penile and vaginal application, intended to moisturize and lubricate, and to enhance the ease and comfort of intimate sexual activity and available in eight quality formulations.

The FDA decision provides pre-market approval for SASMAR® Original, SASMAR® Classic, SASMAR® Warming, SASMAR® Strawberry, SASMAR® Cherry, SASMAR® Vanilla, SASMAR® Pina Colada and SASMAR® Melon personal lubricants. Manufactured in France to the highest quality standards, the product range includes a silicone-based, water-based, warming and multiple flavored variants. Each version is formulated without parabens and packaged in 4ml sachets, 50ml Tubes and premium 60ml airless pumps.

The company advises that SASMAR® brand personal lubricants will be available in the U.S. from October this year.

"This is a substantial approval of eight formulations that offers consumers a diverse choice of product offerings, satisfying the demands of a broad demographic," says John-Michael Mancini, group Chief Executive Officer, SASMAR. "The FDA decision is a key milestone for the company as we continue the rollout of our quality products globally and our introduction into the US market."

SASMAR® brand Personal Lubricants are already trusted by millions of consumers in more than sixty countries globally. The comprehensive FDA approval is reliant on results of rigorous clinical testing and other supporting data to prove substantial equivalence with other leading personal lubricant brand in the United States. SASMAR® brand personal lubricants were determined to meet the FDA’s high standards for biocompatibility in accordance with ISO 10993 for cytotoxicity, vaginal irritation, sensitization and systemic toxicity. Additionally, testing confirmed that all eight formulations are safe for use with natural rubber latex, polyurethane and polyisoprene condoms, the most used condom types worldwide.

The company advises distributors and retailers interested in receiving information and samples of SASMAR® Personal Lubricants to contact their sales department via its website.


SASMAR is a pharmaceutical company focused on the categories of fertility, family planning and female health. Founded in 2005, the company is a major manufacturer of personal lubricant and supplier to international governmental organizations in HIV/AIDS prevention and awareness programs in third world and developing countries.

The founding purpose of SASMAR in 2005 was to provide high quality personal care products that benefited the lives of consumers in Australia and since then the company has grown its product portfolio and international distribution in a very short period. Headquartered in Brussels, Belgium, the group has operations based in Sydney, London, Hong Kong and Chicago and has a presence in more than sixty countries through a network of distribution partners.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards
2. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
3. University of Houston Graduate College of Social Work announces partnership with MD Anderson
4. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
5. AGA announces prestigious awards recognition recipients
6. Announces The Top 3 Heart Rate Monitors
7. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
8. Zane Benefits Announces Wellness HRAs: A New Way to Reward Healthy Employees
9. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
10. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
11. NYC Doc Announces 3 Surprising Ways to Beat Seasonal Allergies
Post Your Comments:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: